Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
For policy makers, healthcare systems, payors and companies with marketed products or services, ensuring equitable access to minimise health disparities should be a priority
Severe liver disease: While GLP-1 medications generally don't require dose adjustments for mild-to-moderate hepatic impairment, those with severe liver disease should exercise particular caution with both the medication and alcohol
Intern.Med 2010;49(16):1717-1725
In those cases, their GLP-1 therapy may not appear in the medication record, which makes potential interactions like this easier to overlook
Journal of Clinical Endocrinology and Metabolism, 106(2), 388-396
US$ 27.82
US$ 26.79
US$ 27.75
US$ 23.98
